This is the authors' abstract. We don't add key points for this paper.
Prostate cancer disproportionately affects men of African ancestry at nearly twice the rate of men of European ancestry despite the advancement of treatment strategies and prevention. In this review, we discuss the underlying causes of these disparities including genetics, environmental/behavioral, and social determinants of health while highlighting the implications and challenges that contribute to the stark underrepresentation of men of African ancestry in clinical trials and genetic research studies. Reducing prostate cancer disparities through the development of personalized medicine approaches based on genetics will require a holistic understanding of the complex interplay of non-genetic factors that disproportionately exacerbate the observed disparity between men of African and European ancestries.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lewis et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: